Polsko-Niemiecke Przedsiębiorstwo Karbensp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-02-12
Share capital
100,000.00 PLN
Registered address
Dygasińskiego 15, 06-400 Ciechanów, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2023, 259 days late).

  • 202517/05/2026
  • 202429/05/2025
  • 202331/03/2025
  • 202219/06/2023
  • 202102/06/2022
  • 202009/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Authorized Representatives

Julian Piotr Rakage 70 – Dyrektor Zarządu
Maria Świerczyńska – Attorney-in-fact (sole)

Manner of representation

The Director of the Management Board acts independently; when the management board is multi-member, joint action of two members of the management board is required.

Ownership

OwnerSharesShare valueStake
100$13,506.2150%
Dieter Willi Schlautek
100$13,506.2150%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 1993-07-05 to 2024-05-31.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Competitors

Name
Adamed PharmaS.A.
Fresenius Kabi Polskasp. z o.o.
Anpharm Przedsiębiorstwo FarmaceutyczneS.A.
BiotonS.A.
Celon PharmaS.A.
SUN-Farmsp. z o.o.
Noris Polskasp. z o.o.
Actifarmsp. z o.o.
Bioresearch PharmaS.A.
Auxilius PharmaS.A.

FAQ

Last updated: 2026-10-15